Pharma Market Access Insights - from Petauri Evidence

Petauri Evidence
  • 3.0 (2)
  • LIFE SCIENCES
  • UPDATED BIMONTHLY

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence. 

  1. Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

    JUL 18

    Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

    Send us a text Uncover the forces driving change in global pricing and access In this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA). At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this episode, our experts, Clare Foy and Adam Brown, are joined by two new additions to the team, Catherine Beecher and Sam Davies, who bring extensive expertise from both consultancy and industry. Ben Spurr (Head of Partnerships, Petauri Evidence) hosts the panel discussion with Clare, Adam, Catherine, and Sam as they explore the key issues facing Pharmaceutical and Medtech companies as they prepare for global launch, navigate payer expectations, and develop value-driven pricing strategies. This episode was first broadcast as a live webinar. Learn more at: https://petauri.com/insights/webinar-global-pricing-market-access-strategies/ Discover our global pricing and market access services at: https://petauri.com/gpma/  To explore your pricing and market access strategy with our experts or to put your question to the panel, email evidence@petauri.com Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    53 min
  2. Transforming Global Market Access: Smarter Resource Management with Local Affiliates

    JUN 3

    Transforming Global Market Access: Smarter Resource Management with Local Affiliates

    Send us a text Discover a smarter way to manage and share market access resources with local affiliates Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? In this webinar we discussed how a centralised platform can streamline resource sharing, ensure access to nationally-relevant evidence, and put the resources your local affiliates need right at their fingertips. The webinar features a conversation with Tim Styche (Market Access & Health Outcomes Director, Smith+Nephew), who shares how his team has solved this challenge with our Global Value Platform. Learn more at: https://petauri.com/insights/transforming-global-market-access-smarter-resource-management-with-local-affiliates-a-live-webinar/ To discuss your needs or arrange a full demo of the platform email evidence@petauri.com   Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    34 min
  3. Communicating value to US Payers: Insights for Pharma and Medtech

    APR 29

    Communicating value to US Payers: Insights for Pharma and Medtech

    Send us a text What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as diverse as the US? In this Global Whispers episode, Louise Maddison (Senior Consultant – Global Market Access, Petauri Evidence) interviews some of our colleagues from Petauri Advisors who are either former payers, or former industry market access leads in the US. Louise puts your questions to:  - Rory Davies – Vice President of Value and Access, Petauri Advisors, with extensive past experience in Chief Clinical roles at Cigna, Flipt and WellDyne - Dan Vanderpoel – Executive Vice President, Strategic Payer Marketing; Head, Client Solutions, Petauri and former Manager, Trade Relations at Humana - Shana Gunderson Hua – Vice President of Value and Access, Petauri Advisors and former Medical Affairs Executive Director at Genentech and former AVP of Pharmaceutical Strategy and Contracting at Cigna and Express Scripts (now Evernorth) We explore what global market access teams need to know about market access and payer engagement in the US. We  explore how and why value messaging, pricing, and launch strategies are developed differently for the US market, compared to other key launch markets, and what this means for global teams preparing for US launch or taking a US-developed proposition internationally. Learn more at: https://petauri.com/insights/communicating-value-to-us-payers-insights-for-pharma-and-medtech/ This episode was first broadcast live as a webinar in March 2025.  Learn more about Petauri Evidence: https://petauri.com/petauri-evidence/ Learn more about Petauri Advisors: https://petauri.com/petauri-advisors/ Meet the ACE team: https://petauri.com/about-us/ace-team/ Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    59 min
  4. Navigating market access: Launch strategies and health economic modelling for medical devices

    APR 24

    Navigating market access: Launch strategies and health economic modelling for medical devices

    Send us a text Discover how health economics can support successful Medical Device launch, proposition development, and market access This episode offers an insightful journey into the world of medical device market access. Specialists from our health economics and market access teams explore the hidden challenges faced by medical devices companies when taking new innovations to healthcare leaders, communicating value and demonstrating evidence, and offer tips on leveraging health economics for a successful launch. Juliet Wallace (Senior Partnerships Coordinator) delves deep with our expert panel into the pivotal role of health economic evaluation in supporting market access for medical devices. Juliet puts audience questions to Hannah Palin (Director, Local Market Access), Calum Jones (Associate Director, Health Economics), and Evelyne Priestman (Consultant, Health Economics). See full details at: https://mtechaccess.co.uk/launch-strategies-health-economic-modelling-medical-devices/ This episode was originally broadcast live as webinar in February 2025.  https://petauri.com/ Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    45 min
  5. Navigating US payer evidence needs to optimise market access

    11/27/2024

    Navigating US payer evidence needs to optimise market access

    Send us a text What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How should evidence be generated, synthesised, and presented for the US market? In this episode, Clare Foy (Director – Global Market Access, Mtech Access) interviews colleagues Nicole Lodowski (Managing Director, Petauri Evidence) and Bob Nordyke (Senior Advisor, Petauri Evidence) about US payer evidence challenges. We explore the evolving evidence needs for US payers. Nicole and Bob share unique perspectives around their extensive experience of driving evidence strategies for US pharmaceutical and medical device launches. Additionally, Nicole and Bob share a ‘sneak peek’ of exclusive insights from a recent Petauri US payer insights survey conducted to better understand the evidence landscape from the US payers’ perspective. They explore: The evolving payer evidence landscape in the USPreferences for clinical and economic evidence by US payersKey differences between the US and other global markets with regard to evidence, HEOR, and market accessOpportunities and challenges when launching new medicines/medical devices/diagnostics in the USInnovative perspectives on evidence planning and strategy for the US marketUS payers’ perspectives, with exclusive insights from Petauri Evidence’s 2024 US payer survey This episode was first broadcast as a live webinar in October 2024. Learn more at: https://mtechaccess.co.uk/navigating-us-payer-evidence-needs/ Explore more about launching in the US market: https://mtechaccess.co.uk/launching-healthcare-products-in-the-us/ Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    58 min
  6. Best practice RWE approaches to support economic modelling for HTA

    11/20/2024

    Best practice RWE approaches to support economic modelling for HTA

    Send us a text How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison? Here, Mtech Access are joined by experts from Arcturis and Delta Hat. Dan Howard (Associate Director – Health Economics, Mtech Access) shares some of the challenges that our clients face when developing HTA-ready health economic models with limited clinical trial data. Joseph O’Reilly (Principal Medical Statistician, Arcturis) introduces solutions to these challenges using RWD and RWE approaches. Nick Latimer (Analyst, Delta Hat; Professor of Health Economics, University of Sheffield; former NICE Appraisal Committee member) discusses how RWE is assessed by HTA committees. Samantha Gillard (Director – HTA, Mtech Access) facilitates the discussion and puts your questions to our experts This episode was first broadcast as a live webinar in October 2024. To request a copy of the slides used or to learn more visit: https://mtechaccess.co.uk/rwe-approaches-economic-modelling-hta/ For support with real-world evidence analysis, health economic modelling of health technology assessment, email info@mtechaccess.co.uk or visit https://mtechaccess.co.uk/ Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    1 hr
  7. NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

    11/18/2024

    NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

    Send us a text How is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decision-makers in the next few months? In August, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by Jo Turl (Former Director of Commissioning, Devon ICS) to explore these challenges. Jo and Karen discuss: How ICBs and Directors of Commissioning prepare for winter pressuresThe current key areas of focus at Place and ICB levelSpecific challenges and pressures facing the NHS now and in the run up to winterImmediate and long-term impact of (expected) new government policiesHow industry can best support the NHS as it plans for winter and beyondHow your field teams can engage with NHS commissioners over the next few monthsThis episode was first broadcast as a live webinar in August 2024. Learn more at https://mtechaccess.co.uk/nhs-winter-planning/ For support with your UK market access and NHS engagement strategy, visit: https://mtechaccess.co.uk/strategic-uk-market-access/ or email info@mtechaccess.co.uk Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    1h 3m
  8. De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

    10/11/2024

    De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

    Send us a text Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a new health technology to the NHS in England? In July 2024, Global Whispers and NHS Whispers came together, to bring you an overarching view of what it takes to access the NHS with a medtech or pharmaceutical innovation. Guest speaker Dr Faris Al-Ramadani who shared his experience of introducing new technologies to the NHS from both sides of the fence: as a PCN Clinical Director and GP Partner, and as a HealthTech and Venture Capital Consultant. The NHS in England is complex and ever changing. Recent years have seen the introduction of new structures, new decision-makers and new priorities. If you’ve fallen out of the loop of what’s happening with the NHS, this webinar is here to help. After de-ciphering some of the new(er) NHS terminologies and structures, we discuss: The key steps for introducing a new health technology to the NHSWho to speak to, when and whereWhat to include in your value proposition to appeal to NHS decision-makers How to best meet key stakeholders’ needsThe challenges of bringing a new technology to the NHS in England Learn more about this webinar at: https://mtechaccess.co.uk/de-mystifying-the-nhs/ Discover more about how we can support your UK launch strategy at: https://mtechaccess.co.uk/strategic-uk-market-access/ This webinar was first broadcast live as a webinar in July 2024 Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

    56 min
See All (69)

Ratings & Reviews

3
out of 5
2 Ratings

About

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence. 

Information

You Might Also Like